Measuring disease activity in Crohn's disease. - Wikidata - awgldk - TriplyDB

Measuring disease activity in Crohn's disease.

Measuring disease activity in Crohn's disease.

http://www.wikidata.org/entity/Q37996312

about

Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?Measuring structural damage in Crohn's disease Assessment of disease behavior in patients with Crohn's disease by MR enterography.

P2860

Q38562177-CF11D216-35EC-42AF-9810-600CA9CDD201 Q41899705-8274362F-2F67-478F-9608-6F15AEEE55AD Q44049254-664AA338-0AF1-4631-B621-7D1732DDB458

P2860

Measuring disease activity in Crohn's disease.

http://www.wikidata.org/entity/Q37996312

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Measuring disease activity in Crohn's disease.

@en

Measuring disease activity in Crohn's disease.

@nl

type

label

Measuring disease activity in Crohn's disease.

@en

Measuring disease activity in Crohn's disease.

@nl

prefLabel

Measuring disease activity in Crohn's disease.

@en

Measuring disease activity in Crohn's disease.

@nl

P1433

Q37996312-6A095836-270E-4B90-BFE5-C4975D6C6ADC

P1476

Q37996312-CA1FA436-338F-4A63-93BE-246B8AD710BE

P2093

Q37996312-027B4474-6EAC-4B9B-B62B-E048467C3564

Q37996312-71C3DD29-4234-4F62-A64F-FD5655B5EA7A

Q37996312-A9919F12-1541-4DBA-AF89-146F2E7694C9

P2860

Q37996312-0E70F57F-E58C-441A-82A6-564B9A250D20

Q37996312-13B61B7E-5721-41F9-962E-1BFCFB4512D6

Q37996312-2B0C6DAA-A7B8-4F44-971B-67DB6C5AB225

Q37996312-2C036920-CDE3-4D5C-98EC-AFF8571C7EB6

Q37996312-2CBEE198-097B-4E0D-84F9-73987A49F8A4

Q37996312-2F5676BB-2733-4106-AC8D-F6D9B56087A2

Q37996312-3415629C-54E1-4EC8-BF27-0A6E125B1115

Q37996312-44150155-7BB9-47F2-871B-61570AEB7AB7

Q37996312-4DC4E8E5-1686-4506-BFD7-5F0651F1F194

Q37996312-508F1D3F-99A7-4225-976E-2BC3FD89975D

P304

Q37996312-CC07E328-16DB-496F-9C90-528FE6C40755

P31

Q37996312-9B81F938-7A56-474A-B57E-EB0A9ED7FDA7

P356

Q37996312-B41F2EED-1781-4FDA-BEF5-5235864B8BA9

P433

Q37996312-A1E79482-5E9C-4C7C-9EF0-8715A3B8F6F7

P478

Q37996312-ABD305B6-99F9-45C7-AF34-B2AF51112E3C

P577

Q37996312-F5C5929B-C14C-4D89-A8DB-94D51C0050EC

P698

Q37996312-446DFEE9-14EB-433F-B393-4982CF1C1F8F

P921

Q37996312-A7C6E728-E714-4099-8E77-DE69B2818CE3

P356

S00261-012-9877-3

P1433

Abdominal Imaging

P1476

Measuring disease activity in Crohn's disease.

@en

P2093

Emma Calabrese

http://www.w3.org/2001/XMLSchema#string

Francesco Pallone

http://www.w3.org/2001/XMLSchema#string

Sara Onali

http://www.w3.org/2001/XMLSchema#string

P2860

A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

A simple index of Crohn's-disease activity

Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease

Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy.

Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI.

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

Review article: monitoring the activity of Crohn's disease.

MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents.

P304

927-932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-012-9877-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22441627

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease